The Keck School of Medicine of USC is launching a large clinical study to determine whether a man-made antibody would slow or stop the progression of Alzheimer’s disease by targeting memory-robbing plaques in the earliest stages of the illness.
Described as … Read More »
When Ray Goldsworthy, PhD, was just 13, he contracted spinal meningitis. Antibiotics saved his life but destroyed the cells in his inner ears responsible for processing sound.
“Within the span of one to two weeks, I went from hearing normally to … Read More »
The Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine of USC is one of 25 premier research institutions that received a $4.7 million award to advance research on Down syndrome. The project, titled “Clinical Trials to Prevent … Read More »